Case Studies

Boston Healthcare has worked with established and emerging companies to create innovative business development strategies. Below are summaries of typical project case studies:

Licensing Strategy & Implementation
A small biotechnology company with promising oncology product candidates in Phase III and Phase I of clinical trials needs immediate funding for on-going clinical development efforts and also seeks to establish strategic relationships that will better position them for a near-to-mid-term IPO. Boston Healthcare identifies a target list of potential partners, initiates discussions with these potential partners, establishes and negotiates the financial terms, and is instrumental in closing a $97 million deal with a large, multi-national pharmaceutical company for both products for our client. With the partner relationship helping to validate the client’s core intellectual property, the client is able to raise an additional $16 million with a successful IPO.

Partnering, Deal Structuring & Negotiation
A small biotechnology company, with an innovative technology platform having applications across a variety of clinical areas, seeks funding to continue the development of their technology and to better position themselves for an IPO. Boston Healthcare is retained to identify those indications best suited for out-licensing. Utilizing a unique screening and assessment approach, Boston Healthcare identifies the optimal out-licensing opportunities. At the same time, Boston Healthcare initiates discussions with a large, multi-national pharmaceutical manufacturer and assists our client in closing a $25 million deal. This enables the company to continue R&D efforts and to enter the public market with greater credibility.

Business Development Assessment & Valuation Modeling
Boston Healthcare has worked with both established and emerging companies to assess the market opportunity for novel specialty drugs. These engagements typically examine everything from market potential, to likely reimbursement milestones, adoption curve modeling, and product forecasts. Detailed primary research is often conducted with a mix of opinion leaders and community practice physicians depending upon stage of development. Boston Healthcare also offers real options and discounted cash flow valuation modeling, often to support business development transactions.

Developing a Branded Business Strategy for a Generic Pharmaceuticals Company
Boston Healthcare worked with this established generic pharmaceuticals company to create a business development strategy for a newly-created branded pharmaceuticals division. Work included prioritized strategic initiatives that combined in-licensing marketed products with development of R&D capabilities capitalizing on core strengths.

Assessing the Business Development Potential for a Bioinformatics Tool Company
Boston Healthcare worked with this life sciences knowledge management software company to outline a business development strategy. Our team examined market trends, competitor profiles, and opportunities in the drug discovery, clinical trials, and patient level informatics arenas. We then went on to develop and compare potential service/business models and probable deal structures and values for the business development group.

Creating Commercialization Strategies for Novel Clinical Diagnostics
Boston Healthcare has worked with both test developers and service providers in the clinical diagnostics arena to assess the market opportunity and to then develop strategies for market entry of new tests or services. These engagements typically examine everything from test or service market potential, to likely reimbursement milestones, adoption curve modeling, and product/service forecasts and financial plans.